Enveric Biosciences, Inc.
ENVB
$5.32
$0.224.31%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 24.48% | 31.85% | -33.64% | 91.63% | -27.98% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -23.52% | -9.63% | -- | -- | -- |
| Prepaid Expenses | -46.71% | -20.03% | -27.96% | 107.29% | -42.65% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 27.85% | 1,078.13% | 700.00% | -99.83% | -69.11% |
| Total Current Assets | 18.51% | 25.94% | -31.59% | 76.80% | -36.97% |
|
|
|||||
| Total Current Assets | 18.51% | 25.94% | -31.59% | 76.80% | -36.97% |
| Net Property, Plant & Equipment | -18.98% | -18.50% | -9.80% | -12.59% | -16.83% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -50.00% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 16.82% | 22.93% | -30.45% | 65.52% | -35.65% |
|
|
|||||
| Total Accounts Payable | -15.02% | -34.32% | 55.56% | 28.27% | -9.47% |
| Total Accrued Expenses | 51.85% | -31.14% | -35.10% | -48.64% | 282.31% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 1.38% | -33.57% | 15.14% | -20.49% | 77.51% |
|
|
|||||
| Total Current Liabilities | 1.38% | -33.57% | 15.14% | -20.49% | 77.51% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 1.38% | -33.57% | 15.14% | -20.49% | 77.51% |
|
|
|||||
| Common Stock & APIC | 2.50% | 2.78% | 0.68% | 4.17% | 0.80% |
| Retained Earnings | -1.95% | -1.69% | -2.33% | -2.06% | -3.07% |
| Treasury Stock & Other | 0.15% | -1.29% | 4.10% | -0.59% | -11.12% |
| Total Common Equity | 20.87% | 58.19% | -44.23% | 145.96% | -59.69% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 20.87% | 58.19% | -44.23% | 145.96% | -59.69% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 20.87% | 58.19% | -44.23% | 145.96% | -59.69% |
|
|
|||||